Classifying Antipsychotic Agents : Need for New Terminology

Overview

Journal CNS Drugs

Specialties Neurology
Pharmacology

Date 2008 Nov 13

PMID 18998742

Citations 6

Authors

Ripu D Jindal

Matcheri S Keshavan

Affiliations

Soon will be listed here.

Abstract

Converging data from multiple lines of research provide growing understanding of the pharmacological basis of the efficacy and tolerability of antipsychotic agents. This review highlights some of the drawbacks of the current practice of classifying antipsychotic agents into first- and second-generation agents, and argues that much of what is known about an antipsychotic agent in terms of its efficacy and tolerability can be predicted from its binding affinity at different receptors. This makes a case for a new system of classification that reflects the receptor binding affinity profiles of individual antipsychotic agents. In its quest to make a compelling case, the review provides detailed explanations for the pharmacological basis of antipsychotic efficacy, antipsychotic-induced weight gain and diabetes mellitus, cognitive effects and other adverse effects.

Citing Articles

Extract of Synedrella nodiflora (L) Gaertn exhibits antipsychotic properties in murine models of psychosis.

Amoateng P, Adjei S, Osei-Safo D, Kukuia K, Oppong Bekoe E, Karikari T BMC Complement Altern Med. 2017; 17(1):389.

PMID: 28784133 PMC: 5547469. DOI: 10.1186/s12906-017-1901-2.

New drug developments in psychosis: Challenges, opportunities and strategies.

Keshavan M, Lawler A, Nasrallah H, Tandon R Prog Neurobiol. 2016; 152:3-20.

PMID: 27519538 PMC: 5362348. DOI: 10.1016/j.pneurobio.2016.07.004.

Sleep and Weight among Our Veterans.

Jindal R J Clin Sleep Med. 2016; 12(7):943-5.

PMID: 27306395 PMC: 4918993. DOI: 10.5664/jcsm.5918.

Lurasidone : in the treatment of schizophrenia.

Sanford M CNS Drugs. 2012; 27(1):67-80.

PMID: 23264146 DOI: 10.1007/s40263-012-0026-x.

Differential use of extended and immediate release quetiapine: a retrospective registry study of Finnish inpatients with schizophrenia spectrum and bipolar disorders.

Hallinen T, Soini E, Granstrom O, Ovaskainen Y, Leinonen E, Koponen H BMJ Open. 2012; 2(4).

PMID: 22761282 PMC: 3391370. DOI: 10.1136/bmjopen-2012-000915.

References

Williams G, Rao S, Goldman-Rakic P . The physiological role of 5-HT2A receptors in working memory. J Neurosci. 2002; 22(7):2843-54. PMC: 6758292. DOI: 20026203. View

Ryu S, Cho E, Park T, Oh S, Jang W, Kim S . -759 C/T polymorphism of 5-HT2C receptor gene and early phase weight gain associated with antipsychotic drug treatment. Prog Neuropsychopharmacol Biol Psychiatry. 2007; 31(3):673-7. DOI: 10.1016/j.pnpbp.2006.12.021. View

Reilly J, Harris M, Keshavan M, Sweeney J . Adverse effects of risperidone on spatial working memory in first-episode schizophrenia. Arch Gen Psychiatry. 2006; 63(11):1189-97. DOI: 10.1001/archpsyc.63.11.1189. View

Nuechterlein K, Barch D, Gold J, Goldberg T, Green M, Heaton R . Identification of separable cognitive factors in schizophrenia. Schizophr Res. 2004; 72(1):29-39. DOI: 10.1016/j.schres.2004.09.007. View

Thornton A, Van Snellenberg J, Sepehry A, Honer W . The impact of atypical antipsychotic medications on long-term memory dysfunction in schizophrenia spectrum disorder: a quantitative review. J Psychopharmacol. 2005; 20(3):335-46. DOI: 10.1177/0269881105057002. View

Silvestre J, Prous J . Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes. Methods Find Exp Clin Pharmacol. 2005; 27(5):289-304. DOI: 10.1358/mf.2005.27.5.908643. View

Passani M, Giannoni P, Bucherelli C, Baldi E, Blandina P . Histamine in the brain: beyond sleep and memory. Biochem Pharmacol. 2007; 73(8):1113-22. DOI: 10.1016/j.bcp.2006.12.002. View

Gautam D, Han S, Hamdan F, Jeon J, Li B, Li J . A critical role for beta cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. Cell Metab. 2006; 3(6):449-61. DOI: 10.1016/j.cmet.2006.04.009. View

Apiquian R, Fresan A, Ulloa R, de la Fuente-Sandoval C, Herrera-Estrella M, Vazquez A . Amoxapine as an atypical antipsychotic: a comparative study vs risperidone. Neuropsychopharmacology. 2005; 30(12):2236-44. DOI: 10.1038/sj.npp.1300796. View

10.

Kapur S, Remington G . Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient. Biol Psychiatry. 2001; 50(11):873-83. DOI: 10.1016/s0006-3223(01)01251-3. View

11.

Peng R, Mansbach R, Braff D, Geyer M . A D2 dopamine receptor agonist disrupts sensorimotor gating in rats. Implications for dopaminergic abnormalities in schizophrenia. Neuropsychopharmacology. 1990; 3(3):211-8. View

12.

Hippius H . The history of clozapine. Psychopharmacology (Berl). 1989; 99 Suppl:S3-5. DOI: 10.1007/BF00442551. View

13.

Correll C, Leucht S, Kane J . Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am J Psychiatry. 2004; 161(3):414-25. DOI: 10.1176/appi.ajp.161.3.414. View

14.

Silvestri S, Seeman M, Negrete J, Houle S, Shammi C, Remington G . Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study. Psychopharmacology (Berl). 2000; 152(2):174-80. DOI: 10.1007/s002130000532. View

15.

Harvey P . Cognitive and functional effects of atypical antipsychotic medications. J Clin Psychiatry. 2006; 67(10):e13. DOI: 10.4088/jcp.1006e13. View

16.

Mizrahi R, Rusjan P, Agid O, Graff A, Mamo D, Zipursky R . Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia. Am J Psychiatry. 2007; 164(4):630-7. DOI: 10.1176/ajp.2007.164.4.630. View

17.

Sica D . Alpha1-adrenergic blockers: current usage considerations. J Clin Hypertens (Greenwich). 2005; 7(12):757-62. PMC: 8109532. DOI: 10.1111/j.1524-6175.2005.05300.x. View

18.

Heres S, Davis J, Maino K, Jetzinger E, Kissling W, Leucht S . Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics. Am J Psychiatry. 2006; 163(2):185-94. DOI: 10.1176/appi.ajp.163.2.185. View

19.

Renuka T, Robinson R, Paulose C . Increased insulin secretion by muscarinic M1 and M3 receptor function from rat pancreatic islets in vitro. Neurochem Res. 2006; 31(3):313-20. DOI: 10.1007/s11064-005-9022-6. View

20.

Fletcher P, Tenn C, Sinyard J, Rizos Z, Kapur S . A sensitizing regimen of amphetamine impairs visual attention in the 5-choice serial reaction time test: reversal by a D1 receptor agonist injected into the medial prefrontal cortex. Neuropsychopharmacology. 2006; 32(5):1122-32. DOI: 10.1038/sj.npp.1301221. View